LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)

Market Cap	4.80B -30.2%
Revenue (ttm)	586.91M -7.9%
Net Income	235.80M -28.9%
EPS	0.68 -29.1%
Shares Out	342.87M
PE Ratio	20.62
Forward PE	8.28
Dividend	0.58 (4.17%)
Ex-Dividend Date	May 27, 2026

Volume	152,000
Open	14.00
Previous Close	14.02
Day's Range	13.75 - 14.14
52-Week Range	8.33 - 19.94
Beta	-0.14
Analysts	Strong Buy
Price Target	29.67 (+112.08%)
Est. Earnings	Nov 20, 2026

About HKG:2291

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices. It operates through Occluder Business and Heart Valve Business segments. The company also researches, develops, manufacture, and sale interventional treatment series occluders for defective congenital heart disease; and manufacture and sale heart valve medical devices. Its products include atrial septal defect, ventricular septal defect, patent du...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Employees: 371
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2291

Financial Performance

In 2025, HKG:2291's revenue was 527.94 million, an increase of 11.94% compared to the previous year's 471.64 million. Earnings were 239.73 million, a decrease of -2.37%.

Financial numbers in CNY

Analyst Summary

According to 2 analysts, the average rating for 2291 stock is "Strong Buy." The 12-month stock price target is $29.67, which is an increase of 112.08% from the latest price.

Price Target

$29.67

(112.08% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 22, 2026

Data Sources Report a data error